ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 25

Activation of the Canonical Wnt Signaling Pathway Is Tissue Dependent in Osteoarthritic Joints: Distinct Mechanisms of Regulation by Wnt Antagonists

Thomas Funck-Brentano1, Wafa Bouaziz1, Hilene Lin1, Valerie Geoffroy1, Eric Hay1 and Martine Cohen-Solal2, 1INSERM U606 Paris 7 university, Paris, France, 2Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, bone metabolism, cartilage, osteoarthritis and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Wnt signaling pathway is a major regulator of bone and cartilage remodeling. Modulation of this pathway has lead to controversial results on joint cartilage in murine osteoarthritis (OA) models. Therefore, this study aims to describe the in vivo activity of Wnt/βcatenin and the expression of Wnt antagonists in joint tissues during the development of OA.

Methods: Joint instability was induced by partial meniscectomy (MNX) at the right knee in TOPGAL mice, which express the lacZ gene under the control of Wnt-RE. Left knee was sham-operated. The mice were sacrificed at baseline, 2, 4, 6 and 9 weeks after surgery (≥ 5 animals per time point). Analysis of the bone microarchitecture of the tibial epiphyses were assessed (Skyscan® 1172) and then the samples were prepared for quantification of OA score, X-gal staining and immunohistochemistry for the expression of Dkk-1, Sclerostin and sFRP-3.

Results: Compared to sham, the number of X-gal positive osteocytes per bone volume decreased at 4 weeks then progressively increased in the subchondral bone (ratios: 0.99 ± 0.01; 0.50 ± 0.08, p<0.05; 1.63 ± 0.43; 2.33 ± 0.81 for each time point, respectively). These changes paralleled those of bone volume/tissue volume. Xgal staining was strongly observed in growing osteophytes. The number of X-gal(+)-chondrocytes was low in articular cartilage at baseline, indicating an inhibition of Wnt pathway, but their number increased in the superficial layers with MNX until 6 weeks. The synovium showed marked staining in MNX knees compared to sham operated knees. Dkk-1 was highly expressed in normal non calcified cartilage and dramatically decreased with OA. Sclerostin and sFRP-3 were only expressed in the calcified layers and moderately increased with OA. The synovium also expressed Dkk-1 and sFRP-3 in OA knees.

Conclusion: During the course of OA, the canonical Wnt signaling pathway is mainly activated in growing osteophytes, subchondral bone and synovium while this activation was moderate in chondrocytes of articular cartilage. Distinct patterns of expression of Wnt antagonists are observed in the joint tissues that indicated multiple mechanisms of regulation of the canonical Wnt signaling pathway.


Disclosure:

T. Funck-Brentano,
None;

W. Bouaziz,
None;

H. Lin,
None;

V. Geoffroy,
None;

E. Hay,
None;

M. Cohen-Solal,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activation-of-the-canonical-wnt-signaling-pathway-is-tissue-dependent-in-osteoarthritic-joints-distinct-mechanisms-of-regulation-by-wnt-antagonists/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology